HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniele Lilleri Selected Research

Cytomegalovirus Infections (Inclusion Disease)

1/2022Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis.
1/2022Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection.
8/2021Congenital Human Cytomegalovirus Infection: A Narrative Review of Maternal Immune Response and Diagnosis in View of the Development of a Vaccine and Prevention of Primary and Non-Primary Infections in Pregnancy.
2/2021Pitfalls in the Serological Diagnosis of Primary Human Cytomegalovirus Infection in Pregnancy Due to Different Kinetics of IgM Clearance and IgG Avidity Index Maturation.
1/2021Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
1/2021Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA.
7/2020Prenatal Management of Congenital Human Cytomegalovirus Infection in Seropositive Pregnant Patients Treated with Azathioprine.
11/2019Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.
3/2015Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
7/2011Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniele Lilleri Research Topics

Disease

57Infections
10/2022 - 06/2001
17Cytomegalovirus Infections (Inclusion Disease)
01/2022 - 04/2003
12COVID-19
06/2022 - 01/2021
5Viremia
07/2019 - 01/2003
5Virus Diseases (Viral Diseases)
01/2016 - 02/2004
5Graft vs Host Disease (Graft-Versus-Host Disease)
12/2015 - 05/2006
3Reinfection
01/2021 - 05/2006
3Acquired Immunodeficiency Syndrome (AIDS)
01/2019 - 01/2003
2Giant Cell Arteritis (Horton Disease)
06/2022 - 01/2022
2Pneumonia (Pneumonitis)
06/2022 - 03/2006
2Herpes Zoster
04/2022 - 08/2021
1Neoplasms (Cancer)
04/2022
1Vaccine-Preventable Diseases
04/2022
1Thrombosis (Thrombus)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Brain Injuries (Brain Injury)
01/2022
1Inflammation (Inflammations)
01/2022
1Severe Acute Respiratory Syndrome
12/2021
1Arthritis (Polyarthritis)
12/2021
1Breakthrough Infections
10/2021
1Chickenpox
08/2021
1Spontaneous Abortion (Miscarriage)
01/2021
1Ulcerative Colitis
07/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2020
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
12/2015
1Coinfection
03/2006
1Glioma (Gliomas)
08/2005
1Astrocytoma (Pilocytic Astrocytoma)
08/2005
1Hodgkin Disease (Hodgkin's Disease)
08/2005
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2005
1Vaccinia
02/2004
1Cytomegalovirus Retinitis
01/2003
1Retinitis
01/2003

Drug/Important Bio-Agent (IBA)

12Immunoglobulin G (IgG)IBA
10/2022 - 04/2011
11VaccinesIBA
06/2022 - 12/2014
10Antiviral Agents (Antivirals)IBA
08/2021 - 06/2003
9Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2001
8AntibodiesIBA
06/2022 - 12/2012
8Neutralizing AntibodiesIBA
04/2022 - 01/2013
8CytokinesIBA
01/2021 - 04/2004
7Messenger RNA (mRNA)IBA
06/2022 - 06/2001
7DNA (Deoxyribonucleic Acid)IBA
08/2019 - 03/2006
5Immunoglobulin M (IgM)IBA
10/2022 - 04/2011
5BNT162 VaccineIBA
06/2022 - 10/2021
5Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2013
5Ganciclovir (Cytovene)FDA LinkGeneric
08/2019 - 01/2003
4Peptides (Polypeptides)IBA
01/2021 - 02/2004
4Viral DNAIBA
09/2017 - 06/2001
4SteroidsIBA
07/2011 - 03/2006
3COVID-19 VaccinesIBA
06/2022 - 10/2021
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2005
3InterferonsIBA
12/2011 - 04/2007
3Interleukin-2 (IL2)IBA
12/2011 - 02/2008
2letermovirIBA
01/2022 - 08/2019
2Pharmaceutical PreparationsIBA
08/2019 - 12/2003
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2015 - 05/2006
2EpitopesIBA
12/2012 - 02/2004
2Nucleic AcidsIBA
06/2003 - 04/2003
1RNA (Ribonucleic Acid)IBA
06/2022
1mRNA VaccinesIBA
06/2022
1Immune Checkpoint InhibitorsIBA
04/2022
1ProteomeIBA
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1C-Reactive ProteinIBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
12/2021
1GlucocorticoidsIBA
12/2021
1Immunoglobulins (Immunoglobulin)IBA
08/2021
1Valacyclovir (Valtrex)FDA LinkGeneric
08/2021
1EnzymesIBA
08/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
07/2020
1Azathioprine (Imuran)FDA LinkGeneric
07/2020
1terminaseIBA
08/2019
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
08/2019
1Cidofovir (Vistide)FDA Link
08/2019
1FoscarnetFDA LinkGeneric
08/2019
1ValganciclovirFDA Link
08/2019
1Viral ProteinsIBA
09/2017
1difluprednateFDA Link
10/2016
1AntigensIBA
01/2016
1Monoclonal AntibodiesIBA
01/2016
1Subunit VaccinesIBA
01/2016
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
12/2014
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
11/2013
1PerforinIBA
12/2011
1HLA Antigens (Human Leukocyte Antigens)IBA
09/2008
1Interferon-gamma (Interferon, gamma)IBA
02/2008
1InterleukinsIBA
04/2007
1Viral AntigensIBA
02/2005
1Indicators and Reagents (Reagents)IBA
04/2004

Therapy/Procedure

14Therapeutics
01/2022 - 04/2003
9Transplantation
01/2022 - 04/2003
6Hematopoietic Stem Cell Transplantation
01/2022 - 08/2005
2Immunotherapy
04/2022 - 01/2016
2Highly Active Antiretroviral Therapy (HAART)
04/2004 - 01/2003
1Prenatal Care (Care, Prenatal)
01/2022
1Organ Transplantation
03/2012
1Cell Transplantation
08/2005
1Drug Therapy (Chemotherapy)
08/2005